Mobile IV therapy makes sense for individuals who value convenience, privacy or recovery at home
but does pose risks, as all NSAIDS do, and is contraindicated during pregnancy
into the effect of BPC 157 on burn-wound healing and burn-gastric lesions in mice, researchers administered BPC-157 10g or 10 ng/kg via injections or topically, at the burn, as a thin layer of cream (50g of BPC 157 dissolved in 2ml of distilled water)
Because standard medicine treats the symptoms
The group treated with BPC-157 healed significantly faster and had greater functional recovery compared to the control group [(Pevec et al., 2010)]
Following these handling practices helps maintain the chemical stability and reproducibility required for reliable experimental use